Article ; Online: Making US poison centers a part of the solution to the COVID-19 pandemic.
Clinical toxicology (Philadelphia, Pa.)
2021 Volume 60, Issue 1, Page(s) 102–114
Abstract: ... 13-Feb-2020 through 15-Apr-2021 National Poison Data System (NPDS) COVID-19 records for changes over ... time. We examined NPDS cases and VAERS COVID-19 vaccine reports 1-Nov-2020 through 2-Apr-2021 ... 052,174 COVID-19 contacts; maximum (peak) contacts/day (12,163) on 16-Mar-2020. As of 5-Apr-2021 ...
| Abstract | Objectives: Our six goals are: 1) describe the relationship between the Methods: We reviewed 13-Feb-2020 through 15-Apr-2021 National Poison Data System (NPDS) COVID-19 records for changes over time. We examined NPDS cases and VAERS COVID-19 vaccine reports 1-Nov-2020 through 2-Apr-2021 for vaccine manufacturer, patient characteristics, state, and clinical effects. Results: PCs reported 1,052,174 COVID-19 contacts; maximum (peak) contacts/day (12,163) on 16-Mar-2020. As of 5-Apr-2021 the US reported >167 million administrations of COVID-19 vaccines (Pfizer-BioNTech, Moderna or Janssen). US PCs reported 162,052 COVID-19 vaccine contacts. Most (61.1%) were medical information calls, 34.9% were drug information, and 2.58% were exposures. Over the same period VAERS reported 49,078 COVID-19 vaccine cases reporting 226,205 symptoms - headache most frequent, ranging from 20% to 40% across the 3 vaccines. Conclusions and recommendations: Although differences exist between the intent and content of the 2 data sets, NPDS volume is compelling. The PC nationwide 800 number facilitates data collection and suggests comingling the 2 data streams has merit. PC professionals received tens of thousands of calls and can: 1) support fact-based vaccine information; 2) contribute vaccine AE follow-up information: 3) advocate for best-case coding and reporting, especially for vaccine adverse experiences. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Adverse Drug Reaction Reporting Systems ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Humans ; Pandemics ; Poison Control Centers ; United States | |||||
| Chemical Substances | COVID-19 Vaccines | |||||
| Language | English | |||||
| Publishing date | 2021-08-27 | |||||
| Publishing country | England | |||||
| Document type | Journal Article | |||||
| ZDB-ID | 204476-6 | |||||
| ISSN | 1556-9519 ; 0009-9309 ; 0731-3810 ; 1556-3650 | |||||
| ISSN (online) | 1556-9519 | |||||
| ISSN | 0009-9309 ; 0731-3810 ; 1556-3650 | |||||
| DOI | 10.1080/15563650.2021.1933510 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 419: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.